Cargando…
Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
Advances in Next Generation Sequencing (NGS) technologies have enabled the accurate detection and quantification of circulating tumor-derived (ct)DNA in most gastrointestinal (GI) cancers. The prognostic and predictive utility of ctDNA in patiets with different stages of colorectal (CRC), gastro-eso...
Autores principales: | Lam, Rachel C. T., Johnson, David, Lam, Gigi, Li, Michelle L. Y., Wong, Joyce W. L., Lam, W. K. Jacky, Chan, K. C. Allen, Ma, Brigette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556664/ https://www.ncbi.nlm.nih.gov/pubmed/36248993 http://dx.doi.org/10.3389/fonc.2022.970242 |
Ejemplares similares
-
Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives
por: Yang, Chaogang, et al.
Publicado: (2019) -
Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016) -
The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020) -
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018) -
Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)